FDA Panel Narrowly Endorses Mela Sciences’ Melanoma Detection System
This article was originally published in The Gray Sheet
Executive Summary
An FDA advisory panel Nov. 18 narrowly endorsed Mela Sciences’ MelaFind melanoma detection system, voting 8-7, with one abstention, that the benefits outweigh any risks.